The Pharmacogenetics Roll Out – Gauging Response to Service [PROGRESS] programme is an NHS England funded transformation project led by researchers at Manchester University NHS Foundation Trust.
Patients across GM and the UK, will have greater access to cutting-edge treatments and clinical trials following a government announcement of £100m of private investment to set up local research hubs.
Recently the NIHR BRC and the NIHR North West Regional Research Delivery Network hosted the Greater Manchester Inflammation Showcase: Musculoskeletal Diseases (MSK) and Dermatology Focus event,
Greater Manchester residents are being encouraged to take part in a research study at MREH that aims to improve the diagnosis and treatment of conditions associated with sight loss.
Research delivered through the NIHR Manchester Biomedical Research Centre (BRC) has contributed to improved diagnostic guidelines for identifying and managing asthma, announced by NICE last week.
Researchers at MFT are recruiting people to take part in a clinical trial to see if an investigational vaccine may be able to protect people 18 years of age or older against the norovirus stomach bug.
New research at Wythenshawe Hospital, has the potential to limit the development of antibiotic resistance while improving patient outcomes, when treating very ill patients with pneumonia and sepsis.
A ground-breaking genetic test that could prevent critically ill newborn babies going deaf if treated with a commonly used antibiotic, is being trialled across 14 NHS neonatal units.